Patent US2943628A successfully refreshed from Google Patents.
US5263984A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Prosthetic ligaments
Assignee: Regen Corp
•
Filing: 1992-04-22
•
Granted: 1993-11-23
•
Expires: 2012-04-22
Abstract
Abstract Disclosed is a prosthetic ligament comprising a Plurality of substantially aligned, elongated filaments. Each filament is a dry, porous, volume matrix of biocompatible and bioresorbable fibrils, at least some of which are crosslinked. The fibrils are short segments of longer fibers of polymeric connective tissue components, or analogs thereof. Each filament establishes a bioresorbable scaffold adapted for ingrowth of ligament fibroblasts, the scaffold and the ingrown fibroblasts supporting natural ligament tensile forces. Also disclosed are methods of fabricating the prosthetic ligament, and methods of regenerating ligamentous tissue in vivo.
Inventors
- 👤 Shu-Tung Li
- 👤 Kevin R. Stone
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 19:22
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/24; A61F; A61F2/00; A61F2/02; A61F2/08; A61L27/20; A61L27/227; A61L27/26; A61L27/40; A61L27/44; A61L27/46; A61L27/48; A61L27/50; A61L27/54; A61L27/58; A61F2/28; A61F2/30; A61F2/3094; A61F2/30965; A61F2/38; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/30062; A61F2002/30108; A61F2002/3011; A61F2002/30112; A61F2002/30131; A61F2002/30199; A61F2002/30224; A61F2002/3023; A61F2002/30667; A61F2002/30677; A61F2/30721; A61F2/30734; A61F2002/30736; A61F2/30942; A61F2002/30957; A61F2/42; A61F2/4261; A61F2002/4271; A61F2002/4274; A61F2002/4276; A61F2002/4279; A61F2002/4282; A61F2002/4284; A61F2002/4287; A61F2002/4289; A61F2002/4292; A61F2002/4294; A61F2002/4297; A61F2210/00; A61F2210/0004; A61F2230/00; A61F2230/0002; A61F2230/0004; A61F2230/0013; A61F2230/0063; A61F2230/0069; A61F2310/00; A61F2310/00005; A61F2310/00365; A61L2300/00; A61L2300/40; A61L2300/452; A61L2430/00; A61L2430/10; A61L2430/38
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
101 words
A prosthetic ligament comprising a plurality of substantially aligned, elongated filaments, each of said filaments being a dry, porous, volume matrix reconstituted from biocompatible and bioresorbable fibrils, said fibrils being short segments of fibers of a polymeric connective tissue-type component, or analog thereof, at least some of said fibrils being crosslinked, at least one of said filaments being a high density filament having a density of about 1.0 to about 1.3 g/cm 3 wherein each of said filaments establishes a bioresorbable scaffold adapted for ingrowth of ligament fibroblasts, and wherein said scaffold and said ingrown fibroblasts support natural ligament tensile forces.
Claim 2
Dependent Claim
101 words
A prosthetic ligament comprising a plurality of substantially aligned, elongated filaments, each of said filaments being a dry, porous, volume matrix reconstituted from biocompatible and bioresorbable fibrils, said fibrils being short segments of fibers of a polymeric connective tissue-type component, or analog thereof, at least some of said fibrils being crosslinked, at least one of said filaments being a high density filament having a density of about 1.0 to about 1.3 g/cm 3 wherein each of said filaments establishes a bioresorbable scaffold adapted for ingrowth of ligament fibroblasts, and wherein said scaffold and said ingrown fibroblasts support natural ligament tensile forces.
Claim 3
Dependent Claim
25 words
The prosthetic ligament of claim 1, wherein said filaments comprise low density filaments having a density of about 0.05 to about 0.40 g/cm 3 .
Claim 4
Dependent Claim
24 words
The prosthetic ligament of claim 2, wherein the density of said low density filaments is from about 0.07 to about 0.30 g/cm 3 .
Claim 5
Dependent Claim
38 words
The prosthetic ligament of claim 1, wherein each of said fibrils are segments of a polymeric connective tissue-type component selected from the group consisting of collagen, elastin, reticulin, cellulose, alginic acid, chitosan, and analogs thereof, and mixtures thereof.
Claim 6
Dependent Claim
13 words
The prosthetic ligament of claim 4, wherein said fibrils comprise segments of collagen.
Claim 7
Dependent Claim
16 words
The prosthetic ligament of claim 1, wherein said crosslinks are formed by a chemical crosslinking reagent.
Claim 8
Dependent Claim
32 words
The prosthetic ligament of claim 6 wherein said crosslinking reagent is selected from the group consisting of glutaraldehyde, formaldehyde, carbodiimides, hexamethylene diisocyanate, bisimidates, polyglycerol polyglycidyl ether, glyoxal, adipyl chloride and mixtures thereof.
Claim 9
Dependent Claim
12 words
The prosthetic ligament of claim 7, wherein said crosslinking agent is formaldehyde.
Claim 10
Dependent Claim
20 words
The prosthetic ligament of claim 1, wherein said filaments further comprise a plurality of polysaccharide molecules interspersed with said fibrils.
Claim 11
Dependent Claim
22 words
The prosthetic ligament of claim 9, wherein at least a portion of said polysaccharide molecules provide crosslinks between ones of said fibrils.
Claim 12
Dependent Claim
39 words
The prosthetic ligament of claim 9, wherein said fibrils are present at a concentration of about 75 to 100% by dry weight, and said polysaccharide molecules are present at a concentration of about 0 to 25% by dry weight.
Claim 13
Dependent Claim
36 words
The prosthetic ligament of claim 9, wherein said polysaccharide molecules are selected from the group consisting of chondroitin 4-sulfate, chondroitin 6-sulfate, keratan sulfate, dermatan sulfate, heparan sulfate, heparin, alginic acid, chitosan, hyaluronic acid, and mixtures thereof.
Claim 14
Dependent Claim
16 words
The prosthetic ligament of claim 9, wherein polysaccharide molecules are dispersed substantially uniformly throughout said matrix.
Claim 15
Dependent Claim
17 words
The prosthetic ligament of claim 9, wherein said polysaccharide molecules are dispersed substantially non-uniformly throughout said matrix.
Claim 16
Dependent Claim
19 words
The prosthetic ligament of claim 1, wherein said fibrils are oriented in a substantially random fashion throughout said filament.
Claim 17
Dependent Claim
19 words
The prosthetic ligament of claim 1, wherein said fibrils are oriented in a substantially ordered fashion throughout said filament.
Claim 18
Dependent Claim
27 words
The prosthetic ligament of claim 1, further comprising a mesh extending from a portion of the outer surface of said filament, said mesh being resorbable and biocompatible.
Claim 19
Independent Claim
132 words
A method of regenerating ligamentous tissue in vivo comprising the steps of: a) providing a prosthetic ligament comprising a plurality of substantially aligned, elongated filaments in a mutually adjacent relationship, each of said filaments being a dry, porous, volume matrix reconstituted from biocompatible and bioresorbable fibrils, said fibrils being short segments of fibers of a polymeric connective tissue-type component, or analogs thereof, at least some of said fibrils being crosslinked, at least one of said filaments being a high density filament having a density of about 1.0 to about 1.3 g/cm 3 wherein each of said filaments establishes a bioresorbable scaffold adapted for ingrowth of ligament fibroblasts; and b) implanting said prosthetic ligament into a joint by surgical procedures, said implanted prosthetic ligament and said ingrown fibroblasts supporting normal ligament tensile forces.
Claim 20
Independent Claim
132 words
A method of regenerating ligamentous tissue in vivo comprising the steps of: a) providing a prosthetic ligament comprising a plurality of substantially aligned, elongated filaments in a mutually adjacent relationship, each of said filaments being a dry, porous, volume matrix reconstituted from biocompatible and bioresorbable fibrils, said fibrils being short segments of fibers of a polymeric connective tissue-type component, or analogs thereof, at least some of said fibrils being crosslinked, at least one of said filaments being a high density filament having a density of about 1.0 to about 1.3 g/cm 3 wherein each of said filaments establishes a bioresorbable scaffold adapted for ingrowth of ligament fibroblasts; and b) implanting said prosthetic ligament into a joint by surgical procedures, said implanted prosthetic ligament and said ingrown fibroblasts supporting normal ligament tensile forces.
Claim 21
Dependent Claim
25 words
The method of claim 18, wherein said providing step (a) comprises providing a prosthetic ligament including a plurality of polysaccharide molecules interspersed with said fibrils.
Claim 22
Dependent Claim
137 words
The method of claim 18, wherein said providing step (a) includes fabricating said prosthetic ligament, said fabricating step comprising the steps of: (a) providing a plurality of essentially pure fibers of a polymeric connective tissue-type component selected from the group consisting of collagen, elastin, reticulin, cellulose, alginic acid, chitosan, and analogs thereof, and mixtures thereof; (b) cutting said fibers into segments shorter than said fibers to form fibrils; (c) aggregating said fibrils into a plurality of elongated filaments; (d) contacting said filaments with a crosslinking reagent for a time sufficient to crosslink at least a portion of said fibrils within said filaments, whereby each filament forms a dry, porous, volume matrix adapted for the ingrowth of ligament fibroblasts; and (e) aligning a plurality of said filaments in mutually adjacent relationship, said aligned filaments forming said prosthetic ligament.
Claim 23
Dependent Claim
36 words
The method of claim 18, wherein said providing step (a) includes fabricating said prosthetic ligament, said fabricating step further comprising aggregating said fibrils with a plurality of polysaccharide molecules to form a plurality of elongated filaments.
References Cited (Backward Citations)
US3443261A
Cited
US3551560A
Cited
US3885638A
Cited
US4085466A
Cited
US4060081A
Cited
GB1515963A
Cited
US4280954A
Cited
US4000525A
Cited
US4055862A
Cited
US4064567A
Cited
US4116898A
Cited
US4291013A
Cited
US4351069A
Cited
US4385404A
Cited
US4334193A
Cited
CA1170001A
Cited
US4378224A
Cited
US4400833A
Cited
US4350629A
Cited
FR2510394A1
Cited
US4502161B1
Cited
US4472840A
Cited
US4502161A
Cited
US4734097A
Cited
US4418691A
Cited
US4458678A
Cited
US4505266A
Cited
US4542539A
Cited
WO1983003536A1
Cited
US4544516A
Cited
US4589881A
Cited
US4661111A
Cited
US4578079A
Cited
US4801299A
Cited
US4448718A
Cited
US4614794A
Cited
GB2164343A
Cited
US4600652A
Cited
US4627853A
Cited
US4932972A
Cited
US4790850A
Cited
US4720512A
Cited
FR2596641A1
Cited
EP0260970A2
Cited
US4766182A
Cited
US4719246A
Cited
US4800219A
Cited
EP0277678A1
Cited
WO1988006872A1
Cited
EP0282091A2
Cited
US5078744A
Cited
US5078745A
Cited
US5171273A
Cited
US5067962A
Cited
US4963146A
Cited
FR2651994A1
Cited
US5092894A
Cited
US5092887A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-11-22 | 1997-05-24 | 1997-11-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-11-22 | 2001-05-24 | 2001-11-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-11-22 | 2005-05-24 | 2005-11-23 | $7700.00 | Window Closed / Lapsed |